Exact Mass: 475.166283
Exact Mass Matches: 475.166283
Found 76 metabolites which its exact mass value is equals to given mass value 475.166283
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-{7-Acetoxy-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-7,8-dihydro-2(6H)-isoquinolinyl}butanoic acid
C25H30ClNO6 (475.17615500000005)
5-O-<6-O-(3-Hydroxy-3-methyl-4-carboxybutanoyl)-beta-D-glucopyranosyl>pyridoxine|5-O-[6-O-(3-Hydroxy-3-methyl-4-carboxybutanoyl)-beta-D-glucopyranosyl]pyridoxine
C20H29NO12 (475.16896740000004)
4-epi-N-2hydroxyethylazachaetoviridin A|chaetomugilide C
C25H30ClNO6 (475.17615500000005)
C20H29NO12_2-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-2-phenylacetamide
C20H29NO12 (475.16896740000004)
C25H30ClNO6_2(6H)-Isoquinolinebutanoic acid, 7-(acetyloxy)-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7,8-dihydro-7-methyl-6,8-dioxo
C25H30ClNO6 (475.17615500000005)
4-[7-acetyloxy-5-chloro-3-[(1E,3E)-3,5-dimethylhepta-1,3-dienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoic acid
C25H30ClNO6 (475.17615500000005)
C25H30ClNO6_2(6H)-Isoquinolinebutanoic acid, 7-(acetyloxy)-5-chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7,8-dihydro-7-methyl-6,8-dioxo
C25H30ClNO6 (475.17615500000005)
Cys Glu Pro Gln
C18H29N5O8S (475.17367540000004)
Cys Glu Gln Pro
C18H29N5O8S (475.17367540000004)
Cys Pro Glu Gln
C18H29N5O8S (475.17367540000004)
Cys Pro Gln Glu
C18H29N5O8S (475.17367540000004)
Cys Gln Glu Pro
C18H29N5O8S (475.17367540000004)
Cys Gln Pro Glu
C18H29N5O8S (475.17367540000004)
Asp Met Asn Pro
C18H29N5O8S (475.17367540000004)
Asp Met Pro Asn
C18H29N5O8S (475.17367540000004)
Asp Asn Met Pro
C18H29N5O8S (475.17367540000004)
Asp Asn Asn Asn
Asp Asn Pro Met
C18H29N5O8S (475.17367540000004)
Asp Pro Met Asn
C18H29N5O8S (475.17367540000004)
Asp Pro Asn Met
C18H29N5O8S (475.17367540000004)
Glu Cys Pro Gln
C18H29N5O8S (475.17367540000004)
Glu Cys Gln Pro
C18H29N5O8S (475.17367540000004)
Glu Pro Cys Gln
C18H29N5O8S (475.17367540000004)
Glu Pro Gln Cys
C18H29N5O8S (475.17367540000004)
Glu Gln Cys Pro
C18H29N5O8S (475.17367540000004)
Glu Gln Pro Cys
C18H29N5O8S (475.17367540000004)
Met Asp Asn Pro
C18H29N5O8S (475.17367540000004)
Met Asp Pro Asn
C18H29N5O8S (475.17367540000004)
Met Asn Asp Pro
C18H29N5O8S (475.17367540000004)
Met Asn Pro Asp
C18H29N5O8S (475.17367540000004)
Met Pro Asp Asn
C18H29N5O8S (475.17367540000004)
Met Pro Asn Asp
C18H29N5O8S (475.17367540000004)
Asn Asp Met Pro
C18H29N5O8S (475.17367540000004)
Asn Asp Asn Asn
Asn Asp Pro Met
C18H29N5O8S (475.17367540000004)
Asn Met Asp Pro
C18H29N5O8S (475.17367540000004)
Asn Met Pro Asp
C18H29N5O8S (475.17367540000004)
Asn Asn Asp Asn
Asn Asn Asn Asp
Asn Pro Asp Met
C18H29N5O8S (475.17367540000004)
Asn Pro Met Asp
C18H29N5O8S (475.17367540000004)
Pro Cys Glu Gln
C18H29N5O8S (475.17367540000004)
Pro Cys Gln Glu
C18H29N5O8S (475.17367540000004)
Pro Asp Met Asn
C18H29N5O8S (475.17367540000004)
Pro Asp Asn Met
C18H29N5O8S (475.17367540000004)
Pro Glu Cys Gln
C18H29N5O8S (475.17367540000004)
Pro Glu Gln Cys
C18H29N5O8S (475.17367540000004)
Pro Met Asp Asn
C18H29N5O8S (475.17367540000004)
Pro Met Asn Asp
C18H29N5O8S (475.17367540000004)
Pro Asn Asp Met
C18H29N5O8S (475.17367540000004)
Pro Asn Met Asp
C18H29N5O8S (475.17367540000004)
Pro Gln Cys Glu
C18H29N5O8S (475.17367540000004)
Pro Gln Glu Cys
C18H29N5O8S (475.17367540000004)
Gln Cys Glu Pro
C18H29N5O8S (475.17367540000004)
Gln Cys Pro Glu
C18H29N5O8S (475.17367540000004)
Gln Glu Cys Pro
C18H29N5O8S (475.17367540000004)
Gln Glu Pro Cys
C18H29N5O8S (475.17367540000004)
Gln Pro Cys Glu
C18H29N5O8S (475.17367540000004)
Gln Pro Glu Cys
C18H29N5O8S (475.17367540000004)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-N-(2-fluorophenyl)-7-methyl- (9CI)
C27H26FN3O2S (475.17296680000004)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-N-(4-fluorophenyl)-7-methyl- (9CI)
C27H26FN3O2S (475.17296680000004)
2-(4-methoxyphenyl)-N-[4-[5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide
3-L-lysyl-AMP
An L-lysyl ester obtained by formal condensation of the carboxy group of L-lysine with the 3-hydroxy group of AMP.
N(6)-(5-adenylyl)-L-lysine
An L-lysine derivative that is the phosphoramidate obtained by formal condensation of the phosphate group of AMP with the side-chain amino group of L-lysine.
N-[5-(4-morpholinylsulfonyl)-2-(1-pyrrolidinyl)phenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide
C23H29N3O4S2 (475.15993940000004)
4-[(3aR,4S,9bR)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
C26H25N3O4S (475.15656900000005)
4-[(3aR,4R,9bR)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
C26H25N3O4S (475.15656900000005)
4-[(3aS,4S,9bS)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
C26H25N3O4S (475.15656900000005)
4-[(3aS,4R,9bS)-4-(hydroxymethyl)-1-(2-methoxyphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
C26H25N3O4S (475.15656900000005)
Buloxibutid
C23H29N3O4S2 (475.15993940000004)
Buloxibutid (AT2 receptor agonist C21) is a agentlike selective angiotensin II AT2 receptor agonist with Ki values of 0.4 nM and >10 μM for the AT2 receptor and AT1 receptor, respectively[1].
(6as)-5-chloro-9-[(2r,3r)-3-hydroxy-2-methylbutanoyl]-2-(2-hydroxyethyl)-6a-methyl-3-[(3s)-3-methylpent-1-en-1-yl]furo[2,3-h]isoquinoline-6,8-dione
C25H30ClNO6 (475.17615500000005)
5-chloro-2-[2-(2-hydroxyethoxy)ethyl]-6a-methyl-3-(3-methylpent-1-en-1-yl)-9-propanoylfuro[2,3-h]isoquinoline-6,8-dione
C25H30ClNO6 (475.17615500000005)